CLDN1 and breast cancer: Interestingly, increased levels of claudin 1 have also been reported for medullary and BRCA1-type breast cancers as well, and it was further proposed that claudin 1 expression can be used to discriminate mutation carriers from sporadic breast cancer cases [107], (Figure 2).